Clinical Trials · NCT07780721
Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- The Affiliated Hospital of Putian University
- Enrollment
- 31
- Start date
- Aug 2026
- Locations
- 1 site, China
- Primary endpoint
- Pathologic Complete Response (pCR) Rate